In line with Icon’s national and international expansion, investment in research remains a priority. We are utilising our long history and depth of clinical trials experience in Australia to continue to establish new research at existing Icon sites and build upon proven team structures to bring the same level of world-class trials to our centres across Singapore, Hong Kong and New Zealand.
View our achievements, milestones and future strategy in the our Annual Research Reports below.
